Pharmacological therapy is now considered a first-line treatment for men with moderate to severe lower urinary tract symptoms. Given the success of antimuscarinic agents, a-sympathetic blockers, and 5-a-reductase inhibitors in treating symptoms, the interest in combination therapy has grown. Despite this, large-scale trials to test the efficacy of such combination therapy are still lacking.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11934-007-0033-5 | DOI Listing |
Publication Analysis
Top Keywords
lower urinary
8
urinary tract
8
tract symptoms
8
5-a-reductase inhibitors
8
combination therapy
8
male lower
4
symptoms treatment
4
treatment a-blockers
4
a-blockers 5-a-reductase
4
inhibitors antimuscarinics
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!